Search results
Ozempic manufacturer Novo Nordisk launches study to find drug’s impact on reduced alcohol cravings
theGrio· 6 hours agoDoes Ozempic lower a user’s desire to drink alcohol — and if so, how? The manufacturer behind the popular medication is on a mission to find out. Novo Nordisk will begin a 28-week study on Monday ...
Explained: What is Hepatitis A that is causing an outbreak in Kerala
Investing.com· 4 days agoNew Delhi, May 17 (IANS) Vaccination, hygiene, and a balanced diet are the major ways to prevent...
Eat the Right Type of Sugar With These 6 Natural Alternatives
CNET· 2 days agoAccording to the US Centers for Disease Control and Prevention, the average adult consumes 17...
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024...
Benzinga· 5 hours agoKorro Bio, Inc. (Korro) KRRO, a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases, is presenting new preclinical data ...
Prometheus Laboratories Presents Data Demonstrating Clinical Validity, Utility, and Positive...
Digital Journal· 10 hours agoPRESS RELEASE Published May 20, 2024 ACCESSWIRE SAN DIEGO, CA / ACCESSWIRE / May 20, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare announced that nine ...
New Study Analyzes the Effects of THCV, CBD on Weight Loss
High Times· 4 days agoNew research, which was published in the journal Cannabis, shows evidence of the weight loss effects of cannabinoids such as THCV and CBD. The study specifically analyzed metabolic syndrome, ...
New gel could make drinking alcohol less harmful
Futurity· 6 days agoResearchers have developed a protein-based gel that breaks down alcohol in the gastrointestinal tract without harming the body. In the future, people who...
Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP...
Benzinga· 2 days agoResults from a Phase 2 study show combination of OCA 5-10mg and bezafibrate 400mg induced the greatest percent change from baseline in ALP at Month 6 OCA and bezafibrate combination therapy has acceptable
Doctor explains differences between types of hepatitis
WKMG ClickOrlando· 3 days agoEach morning on “Breakfast with Bridgett” on News 6 Plus, we have interesting stories and...
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal...
The Woonsocket Call· 3 days agoMallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome ( ...